Anawil Wire and Engineering will debut in the trade-for-trade segment
Anawil Wire and Engineering has been placed in the trade-for-trade segment. Every trade in that segment settles by delivery — intraday squaring off is not permitted.
IPO news
Filings from NSE and SEBI that move Indian IPOs — listing notices, issue circulars, press releases and public notices — alongside our own analysis. Every official item links straight to the document it came from, and to the issue it concerns where there is one.
Trading of Rights Entitlements pursuant to Rights Issue of Shanti Gold International Limited
Shanti Gold International Limited has launched its rights issue to raise ₹99.83 crores by issuing 46,43,471 equity shares. For shareholders and investors looking to participate or monetize their holdings, the trading of Rights Entitlements (REs) is a critical component of this corporate action.
A Complete Guide to the Trading of Rights Entitlements (REs): Genesys International Corporation Limited
As Genesys International Corporation Limited rolls out its highly anticipated rights issue, eligible shareholders and market participants are gearing up for the trading of Rights Entitlements (REs).
Shukra Pharmaceuticals clears its NSE listing formalities
NSE has admitted Shukra Pharmaceuticals to listing. The listing date will follow in a separate circular.
Swaraj Suiting Limited Gears Up for Main Board Migration: A New Era of Growth
Ardee Industries gets its NSE ticker: ARDEE
NSE has admitted Ardee Industries to listing under the symbol ARDEE (ISIN INE0XNF01022). The listing date will follow in a separate circular.
Listing of Equity shares of Annapurna Swadisht Limited on Capital Market Segment (Main Board) pursuant to migration from SME Emerge platform
Where this comes from
Items marked NSE or SEBI are the exchange’s or the regulator’s own words, discovered by a crawler that checks their publication feeds every two hours. We store the headline, the date and a link — never a copy of the document itself, so what you read on the filing is always the filing.
Items marked UpcomingIPO are written by us. They are commentary, not official communication, and nothing in them is investment advice or a recommendation to apply for any issue.